See below for more ASCO21 abstracts from IQVIA authors.  

Breast cancer survivorship and level of institutional involvement utilizing integrative oncology.

Publication-Only Abstracts: Health Services Research and Quality Improvement

View Abstract

 

Awareness, perceptions, and usage of whole person integrative oncology practices: Similarities and differences between breast cancer patients and oncologists.

Publication-Only Abstracts: Symptoms and Survivorship

View Abstract

 

Results from VERONICA: A randomized, phase II study of second-/third-line venetoclax (VEN) + fulvestrant (F) versus F alone in estrogen receptor (ER)-positive, HER2-negative, locally advanced, or metastatic breast cancer (LA/MBC).

Oral Abstract Session: Breast Cancer—Metastatic

View Abstract

 

A phase 1 study of an off-the shelf, multi-neoantigen vector (ADXS-503) in subjects with metastatic non-small cell lung cancer (NSCLC) progressing on pembrolizumab as last therapy.

Poster Session: Developmental Therapeutics—Immunotherapy

View Abstract

 

An international, multicenter, real-world analysis of epithelial ovarian cancer treatment and outcomes.

Poster Session: Gynecologic Cancer

View Abstract

 

Obinutuzumab short-duration infusion (SDI) in previously untreated advanced follicular lymphoma: Results from the end of induction analysis of the phase IV GAZELLE study.

Poster Session: Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

View Abstract

 

Patient-reported symptoms, functioning, and quality of life (QoL) in patients treated with cemiplimab monotherapy for first-line treatment of advanced NSCLC with PD-L1 ≥50%: Results from EMPOWER-Lung 1 study.

Poster Session: Lung Cancer—Non-Small Cell Metastatic

View Abstract

 

Health-related quality of life (HRQoL) in patients (pts) with locally advanced basal cell carcinoma (laBCC) treated with cemiplimab: Analysis of a phase II, open-label clinical trial.

Poster Session: Melanoma/Skin Cancers

View Abstract

 

The impact of cancer-related diarrhea on changes in cancer therapy patterns.

Poster Session: Symptoms and Survivorship

View Abstract

 

Oncology clinical research landscape in Middle East and North Africa (MENA) region: Challenges and proposed solutions.

Publication-Only Abstracts: Care Delivery and Regulatory Policy

View Abstract

 

OEN: Multi-center, international, real-world evidence studies performed using health records without data pooling—The use of a common data model and shared analytical methods.

Publication-Only Abstracts: Care Delivery and Regulatory Policy

View Abstract

 

Phase I study of BJ-001, a tumor-targeting interleukin-15 fusion protein, in patients with solid tumor.

Publication-Only Abstracts: Developmental Therapeutics—Immunotherapy

View Abstract

 

Cost-effectiveness of atezolizumab monotherapy versus pembrolizumab monotherapy for first-line (1L) treatment of metastatic non-small cell lung cancer (mNSCLC).

Publication-Only Abstracts: Health Services Research and Quality Improvement

View Abstract

 

Characterizing unplanned resource utilization associated with cancer-related diarrhea.

Publication-Only Abstracts: Health Services Research and Quality Improvement

View Abstract

 

Healthcare utilization and costs associated with cancer-related diarrhea.

Publication-Only Abstracts: Health Services Research and Quality Improvement

View Abstract

 

Incidence of pneumonitis among limited-stage small cell lung cancer patients exposed to concurrent chemoradiation: A systematic literature review and meta-analysis.

Publication-Only Abstracts: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

View Abstract

 

Chemoradiation-induced pneumonitis in patients with unresectable stage III non-small cell lung cancer: A meta-analysis.

Publication-Only Abstracts: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

View Abstract

 

Psychometric properties of patient reported outcome (PRO) instruments in patients with small cell lung cancer (SCLC) in RESILIENT part 1.

Publication-Only Abstracts: Symptoms and Survivorship

View Abstract